These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1165476)

  • 61. Passive transfer of hypersensitivity to lepromin.
    Goihman-Yahr M; Ferraresi RW; Raffel S
    Proc Soc Exp Biol Med; 1969 Feb; 130(2):390-3. PubMed ID: 5765271
    [No Abstract]   [Full Text] [Related]  

  • 62. Autoimmune response to acetylcholine receptor.
    Patrick J; Lindstrom J
    Science; 1973 May; 180(4088):871-2. PubMed ID: 4706680
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Humoral indices of the resistance of guinea pigs in brucellosis infections].
    Vershilova PA; Chernysheva MI
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Aug; 44(8):77-81. PubMed ID: 5615866
    [No Abstract]   [Full Text] [Related]  

  • 64. [Experimental polymyositis induced by the injection of acetylcholine receptors. Study of the lesions in rats and guinea pigs].
    Schwartz J; Eyquem A; Sobel A
    C R Acad Hebd Seances Acad Sci D; 1976 Mar; 282(12):1215-8. PubMed ID: 819168
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Therapies Directed Against B-Cells and Downstream Effectors in Generalized Autoimmune Myasthenia Gravis: Current Status.
    Beecher G; Putko BN; Wagner AN; Siddiqi ZA
    Drugs; 2019 Mar; 79(4):353-364. PubMed ID: 30762205
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High numbers of autoantigen-reactive mononuclear cells expressing interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) are present in cord blood.
    Yu M; Fredrikson S; Link J; Link H
    Clin Exp Immunol; 1995 Jul; 101(1):190-6. PubMed ID: 7542576
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Carbamylcholine modulation of E-rosette formation. Effect of plasmapheresis in myasthenia gravis.
    Mizuno Y; Humphrey J; Dosch HM; Gelfand EW
    Clin Exp Immunol; 1982 Jul; 49(1):209-16. PubMed ID: 6982131
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The relation of clinical disease to antibody titre, proliferative response and neurophysiology in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Clin Exp Immunol; 1983 Mar; 51(3):543-50. PubMed ID: 6851245
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunopathology of acetylcholine receptors in myasthenia gravis.
    Seybold ME; Lindstrom JM
    Springer Semin Immunopathol; 1982; 5(4):389-412. PubMed ID: 6761884
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Experimental autoimmune myasthenia gravis.
    Lindstrom J
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):568-76. PubMed ID: 6249892
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Acetylcholine receptor-specific suppressive T-cell factor from a retrovirally transformed T-cell line.
    Sinigaglia F; Gotti C; Castagnoli R; Clementi F
    Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7569-73. PubMed ID: 6095305
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.
    Pachner AR
    Yale J Biol Med; 1987; 60(2):169-77. PubMed ID: 3495075
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Myasthenia gravis treatment: twelve years experience on 110 patients.
    Valli G; Jann S; Premoselli S; Scarlato G
    Ital J Neurol Sci; 1987 Dec; 8(6):593-601. PubMed ID: 3429218
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunopathologic events at the endplate in myasthenia gravis.
    Ashizawa T; Appel SH
    Springer Semin Immunopathol; 1985; 8(3):177-96. PubMed ID: 2413561
    [No Abstract]   [Full Text] [Related]  

  • 75. Studies of human myasthenia gravis: electrophysiological and ultrastructural evidence compatible with antibody attachment to acetylcholine receptor complex.
    Rash JE; Albuquerque EX; Hudson CS; Mayer RF; Satterfield JR
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4584-8. PubMed ID: 1070009
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Progress in myasthenia gravis.
    Havard CW
    Br Med J; 1977 Oct; 2(6093):1008-11. PubMed ID: 336138
    [No Abstract]   [Full Text] [Related]  

  • 77. Streptococcal-induced cell-mediated-immune destruction of cardiac myofibers in vitro.
    Yang LC; Soprey PR; Wittner MK; Fox EN
    J Exp Med; 1977 Aug; 146(2):344-60. PubMed ID: 327015
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis.
    Lennon VA; Seybold ME; Lindstrom JM; Cochrane C; Ulevitch R
    J Exp Med; 1978 Apr; 147(4):973-83. PubMed ID: 206648
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Passive transfer of experimental autoimmune myasthenia by lymph node cells in inbred guinea pigs.
    Tarrab-Hazdi R; Aharonov A; Abramsky O; Yaar I; Fuchs S
    J Exp Med; 1975 Sep; 142(3):785-9. PubMed ID: 1165476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.